These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27765050)

  • 61. A biochemical and genetic study of Leishmania donovani pyruvate kinase.
    Sandoval W; Isea R; Rodriguez E; Ramirez JL
    Gene; 2008 Nov; 424(1-2):25-32. PubMed ID: 18725273
    [TBL] [Abstract][Full Text] [Related]  

  • 62. LMOh7858_0369, a gene encoding a putative leucine-rich repeat-containing protein, is required for virulence of Listeria monocytogenes.
    Zhang T; Bae D; Wang C
    FEMS Microbiol Lett; 2016 May; 363(9):. PubMed ID: 26976852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apoptotic protein profile in Leishmania donovani after treatment with hexaazatrinaphthylenes derivatives.
    López-Arencibia A; Martín-Navarro CM; Sifaoui I; Reyes-Batlle M; Wagner C; Lorenzo-Morales J; Piñero JE
    Exp Parasitol; 2016 Jul; 166():83-8. PubMed ID: 27060614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
    Rachamim N; Jaffe CL
    J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis.
    Gannavaram S; Davey S; Lakhal-Naouar I; Duncan R; Nakhasi HL
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2707. PubMed ID: 24587462
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Leishmania donovani asparaginase variants exhibit cytosolic localization.
    Tiwari K; Dubey VK
    Int J Biol Macromol; 2018 Jul; 114():35-39. PubMed ID: 29551509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alkaloids and Leishmania donovani UDP-Galactopyarnosemutase: A Novel Approach in Drug Designing Against Visceral Leishmaniasis.
    Srivastava A; Chandra D
    Infect Disord Drug Targets; 2018; 18(2):145-155. PubMed ID: 28595543
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
    Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
    Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
    Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
    Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification and characterization of a novel Ribose 5-phosphate isomerase B from Leishmania donovani.
    Kaur PK; Dinesh N; Soumya N; Babu NK; Singh S
    Biochem Biophys Res Commun; 2012 Apr; 421(1):51-6. PubMed ID: 22483752
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Understanding the importance of conservative hypothetical protein LdBPK_070020 in Leishmania donovani and its role in subsistence of the parasite.
    Bhardwaj R; Kumar R; Singh SK; Selvaraj C; Dubey VK
    Arch Biochem Biophys; 2016 Apr; 596():10-21. PubMed ID: 26926257
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bioinformatics analysis of four proteins of Leishmania donovani to guide epitopes vaccine design and drug targets selection.
    He J; Huang F; Li J; Chen Q; Chen D; Chen J
    Acta Trop; 2019 Mar; 191():50-59. PubMed ID: 30582920
    [TBL] [Abstract][Full Text] [Related]  

  • 75. L. donovani XPRT: Molecular characterization and evaluation of inhibitors.
    Patel B; Patel D; Parmar K; Chauhan R; Singh DD; Pappachan A
    Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):426-441. PubMed ID: 29233758
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure of internalin C from Listeria monocytogenes.
    Ooi A; Hussain S; Seyedarabi A; Pickersgill RW
    Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1287-93. PubMed ID: 17057330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Leishmania virulence: it's a knock out!
    Handman E
    Trends Parasitol; 2001 Feb; 17(2):60. PubMed ID: 11228002
    [No Abstract]   [Full Text] [Related]  

  • 78. Cathepsin B gene disruption induced Leishmania donovani proteome remodeling implies cathepsin B role in secretome regulation.
    Gerbaba TK; Gedamu L
    PLoS One; 2013; 8(11):e79951. PubMed ID: 24244582
    [TBL] [Abstract][Full Text] [Related]  

  • 79. c-Myc is a novel
    Colineau L; Lambertz U; Fornes O; Wasserman WW; Reiner NE
    J Biol Chem; 2018 Aug; 293(33):12805-12819. PubMed ID: 29934305
    [No Abstract]   [Full Text] [Related]  

  • 80. Identification of two natural compound inhibitors of Leishmania donovani Spermidine Synthase (SpdS) through molecular docking and dynamic studies.
    V M V; Dubey VK; Ponnuraj K
    J Biomol Struct Dyn; 2018 Aug; 36(10):2678-2693. PubMed ID: 28797195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.